The company's financial position is highly vulnerable, evidenced by a negative equity balance of $3.7M and a critically low current ratio of 0.23 as of 2025Q2.
| Total Current Assets | 1.31M | 1.04M | 762.88K | 723.44K | 25.03M | 4.35M | 4.27M |
| Cash & Short-Term Investments | 176.58K | 345.14K | 237.6K | 189K | 57.54K | 190K | 250.77K |
| Cash Only | 176.58K | 345.14K | 237.6K | 189K | 57.54K | 190K | 250.77K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 426.69K | 334.2K | 170.27K | 239.19K | 192.85K | 4.09M | 1.61M |
| Days Sales Outstanding | 20.69 | 17.89 | 15.49 | 23.55 | 18.7 | 327.35 | 66.41 |
| Inventory | 116.84K | 2.84K | 128.98K | 0 | 648.16K | 0 | 0 |
| Days Inventory Outstanding | 11.2 | 0.27 | 14.49 | - | 81.74 | - | - |
| Other Current Assets | 71.54K | 357.18K | 226.03K | 295.25K | 24.12M | 2.8K | 2.35M |
| Total Non-Current Assets | 816.01K | 677.2K | 967.34K | 587.07K | 602.56K | 3.65M | 1.61M |
| Property, Plant & Equipment | 322.82K | 332.29K | 316.26K | 206.99K | 124.5K | 161.16K | 137.41K |
| Fixed Asset Turnover | 16.15x | 20.52x | 12.68x | 17.91x | 30.24x | 28.29x | 64.59x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 992.69K | 1.01M |
| Intangible Assets | 260.37K | 161.43K | 337.3K | 0 | 0 | 289.96K | 461.29K |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 2.2M | 0 |
| Other Non-Current Assets | 232.82K | 183.47K | 281.38K | 380.07K | 478.06K | 2.2M | 0 |
| Total Assets | 2.12M | 1.72M | 1.73M | 1.31M | 25.63M | 8M | 5.88M |
| Asset Turnover | 2.70x | 3.97x | 2.32x | 2.83x | 0.15x | 0.57x | 1.51x |
| Asset Growth % | 38.89% | -0.78% | 32.01% | -94.89% | 220.4% | 36.07% | - |
| Total Current Liabilities | 5.71M | 5.84M | 4.14M | 8.72M | 29.12M | 7.32M | 6.09M |
| Accounts Payable | 316.51K | 14.15K | 25.89K | 1.29K | 1.46M | 2.82M | 1.48M |
| Days Payables Outstanding | 15.6 | 1.35 | 2.91 | 0.16 | 184.3 | 311.01 | 108.13 |
| Short-Term Debt | 2.06M | 2.2M | 1.04M | 3.17M | 3.57M | 353.73K | 657.17K |
| Deferred Revenue (Current) | 477.92K | 522.03K | 477.92K | 0 | -3.69M | 0 | 0 |
| Other Current Liabilities | 636.07K | 125K | -624 | 4.6M | 25.14M | 3.82M | 3.46M |
| Current Ratio | 0.23x | 0.18x | 0.18x | 0.08x | 0.86x | 0.59x | 0.70x |
| Quick Ratio | 0.21x | 0.18x | 0.15x | 0.08x | 0.84x | 0.59x | 0.70x |
| Cash Conversion Cycle | 16.29 | 16.81 | 27.08 | - | -83.87 | - | - |
| Total Non-Current Liabilities | 141.48K | 148.55K | 160.91K | 75.11K | 15.02K | 82.95K | 104.3K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 269.17K | 67.47K | 51.8K | 75.11K | 15.02K | 33.65K | 25.88K |
| Deferred Tax Liabilities | 76.7K | 81.08K | 76.7K | 0 | 0 | 49.29K | 0 |
| Other Non-Current Liabilities | 58.7K | 0 | 32.4K | 0 | 0 | 0 | 78.42K |
| Total Liabilities | 5.85M | 5.98M | 4.3M | 8.79M | 29.14M | 7.4M | 6.2M |
| Total Debt | 2.28M | 2.4M | 1.27M | 3.37M | 3.63M | 462.31K | 709.97K |
| Net Debt | 2.11M | 2.06M | 1.03M | 3.19M | 3.57M | 272.31K | 459.2K |
| Debt / Equity | -0.61x | - | - | - | - | 0.77x | - |
| Debt / EBITDA | -1.15x | - | - | - | - | - | - |
| Net Debt / EBITDA | -1.06x | - | - | - | - | - | - |
| Interest Coverage | -46.56x | -10.92x | -392.00x | -362.18x | -264.57x | 8.46x | -13.58x |
| Total Equity | -3.73M | -4.27M | -2.57M | -7.48M | -3.51M | 600.05K | -317.36K |
| Equity Growth % | 141.66% | -65.92% | 65.62% | -113.34% | -684.46% | 289.08% | - |
| Book Value per Share | -2.01 | -2.30 | -1.58 | -6.53 | -5.83 | 1.30 | -0.86 |
| Total Shareholders' Equity | -3.71M | -4.25M | -2.55M | -7.5M | -3.52M | 521.23K | -360.59K |
| Common Stock | 47.83M | 48.83M | 47.81M | 27.43M | 21.31M | 334.86K | 334.86K |
| Retained Earnings | -51.3M | -52.87M | -50.1M | -34.74M | -24.7M | 180.33K | -684.5K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -234.37K | -210.99K | -260K | -185.47K | -125.69K | 6.04K | -10.96K |
| Minority Interest | -16.75K | -12.58K | -19.01K | 16.61K | 13.48K | 78.82K | 43.23K |
Imminent liquidity and dilution
As reported in financial statements, EUDA's total assets have contracted significantly from $25.6M in 2022Q4 to $2.1M in 2025Q2, reflecting a persistent erosion of the capital base that underscores the company's ongoing struggle to achieve a sustainable, self-funding operational trajectory within the Singaporean healthcare market.
The consistent decline in total assets alongside a deepening deficit in retained earnings suggests that the company is consuming its capital base to fund operating losses rather than investing in productive growth. This trajectory indicates that the business model has yet to reach a point of stability, leaving the balance sheet increasingly fragile.
Based on the most recent quarterly data, EUDA maintains a current ratio of 0.23, which, according to reported figures, highlights a severe inability to cover short-term obligations and suggests that the company's cash runway is likely exhausted, necessitating immediate and potentially dilutive external capital to maintain operations.
A current ratio well below 1.0 is a clear indicator of acute liquidity stress, implying that current liabilities significantly outweigh the company's liquid assets. Investors should monitor this closely, as the lack of a sufficient cash buffer leaves the firm with virtually no margin for error in its operational execution.
According to the company's balance sheet, EUDA has reported negative equity of $3.7M as of 2025Q2, a trend that, as evidenced by historical filings, has persisted for several quarters and signals that accumulated losses have completely wiped out the initial capital invested by shareholders.
The persistent negative equity position suggests that the company is technically insolvent on a book-value basis, which typically complicates access to traditional debt financing. This state of affairs places the entire burden of future funding on equity markets, which may lead to substantial dilution for existing shareholders.
As indicated by the provided data, the presence of $260.4K in goodwill on a balance sheet with only $2.1M in total assets warrants further investigation, as it suggests that a significant portion of the firm's remaining value is tied to intangible assets that may be subject to impairment.
The reliance on goodwill in a balance sheet that is already showing signs of distress is concerning, as it may mask the true lack of tangible assets available to creditors. If the company's growth strategy fails to materialize, these intangibles could be written down, further exacerbating the already negative equity position.
Quick answers to the most common questions about buying EUDA stock.
As of 2025, EUDA Health Holdings Limited (EUDA) had total assets of $1.7M including $1.0M in current assets.
EUDA Health Holdings Limited (EUDA) carries total debt of $2.4M, offset by $0.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
EUDA Health Holdings Limited (EUDA) has total shareholders' equity (book value) of $-4.3M ($-2.30 book value per share). Book value represents the net worth of the company belonging to common stock holders.
EUDA Health Holdings Limited (EUDA) reported a current ratio of 0.18x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.